Chevy Chase Trust’s Idexx Laboratories IDXX Stock Holding History

Chevy Chase Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.8M	Sell	40,596 -1,161	-3%	-$744K	0.07%	248
2025 Q4	$28.2M	Buy	41,757 +912	+2%	+$621K	0.08%	209
2025 Q3	$26.1M	Sell	40,845 -1,636	-4%	-$993K	0.07%	228
2025 Q2	$22.8M	Sell	42,481 -494	-1%	-$236K	0.07%	244
2025 Q1	$18M	Sell	42,975 -42	-0.1%	-$18.2K	0.06%	273
2024 Q4	$17.8M	Sell	43,017 -1,132	-3%	-$497K	0.05%	281
2024 Q3	$22.3M	Sell	44,149 -988	-2%	-$480K	0.07%	242
2024 Q2	$22M	Sell	45,137 -871	-2%	-$437K	0.07%	230
2024 Q1	$24.8M	Sell	46,008 -428	-0.9%	-$234K	0.08%	217
2023 Q4	$25.8M	Sell	46,436 -243	-0.5%	-$114K	0.09%	199
2023 Q3	$20.4M	Sell	46,679 -1,090	-2%	-$544K	0.08%	227
2023 Q2	$24M	Sell	47,769 -375	-0.8%	-$180K	0.09%	200
2023 Q1	$24.1M	Buy	48,144 +484	+1%	+$232K	0.1%	199
2022 Q4	$19.4M	Sell	47,660 -3,194	-6%	-$1.24M	0.08%	237
2022 Q3	$16.6M	Buy	50,854 +105	+0.2%	+$38.6K	0.07%	261
2022 Q2	$17.8M	Sell	50,749 -249	-0.5%	-$102K	0.07%	248
2022 Q1	$27.9M	Buy	50,998 +83	+0.2%	+$43.7K	0.1%	194
2021 Q4	$33.5M	Sell	50,915 -1,383	-3%	-$868K	0.11%	175
2021 Q3	$32.5M	Sell	52,298 -2,108	-4%	-$1.42M	0.11%	167
2021 Q2	$34.4M	Sell	54,406 -2,990	-5%	-$1.65M	0.12%	169
2021 Q1	$28.1M	Sell	57,396 -4,347	-7%	-$2.18M	0.1%	191
2020 Q4	$30.9M	Sell	61,743 -1,353	-2%	-$605K	0.11%	173
2020 Q3	$24.8M	Sell	63,096 -5,277	-8%	-$1.95M	0.1%	186
2020 Q2	$22.6M	Sell	68,373 -4,591	-6%	-$1.33M	0.09%	202
2020 Q1	$17.7M	Buy	72,964 +1,283	+2%	+$335K	0.08%	231
2019 Q4	$18.7M	Sell	71,681 -212	-0.3%	-$55.9K	0.07%	277
2019 Q3	$19.6M	Buy	71,893 +101	+0.1%	+$28.1K	0.08%	257
2019 Q2	$19.8M	Buy	71,792 +72	+0.1%	+$17.7K	0.08%	255
2019 Q1	$16.6M	Buy	71,720 +771	+1%	+$159K	0.07%	295
2018 Q4	$13.2M	Sell	70,949 -125	-0.2%	-$25.6K	0.06%	294
2018 Q3	$17.7M	Sell	71,074 -1,987	-3%	-$482K	0.07%	279
2018 Q2	$15.9M	Sell	73,061 -561	-0.8%	-$116K	0.07%	302
2018 Q1	$14.1M	Sell	73,622 -1,935	-3%	-$357K	0.06%	317
2017 Q4	$11.8M	Sell	75,557 -719	-0.9%	-$113K	0.05%	371
2017 Q3	$11.9M	Buy	76,276 +130	+0.2%	+$20.6K	0.05%	357
2017 Q2	$12.3M	Buy	76,146 +97	+0.1%	+$15.8K	0.06%	337
2017 Q1	$11.8M	Buy	+76,049	New	+$10.5M	0.06%	340

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chevy Chase Trust's IDXX Position: Q1 2026 in Review

Chevy Chase Trust reduced its Idexx Laboratories (IDXX) stake by 2.8% in Q1 2026, selling an estimated $744K and leaving 40,596 shares worth $22.8M. The position accounts for 0.07% of the portfolio, ranked #248.

Chevy Chase Trust first reported a position in IDXX in Q1 2017 and has held it in 37 quarters since. The position peaked at $34.4M in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Chevy Chase Trust held 40,596 shares of Idexx Laboratories worth $22.8M as of Q1 2026.
Chevy Chase Trust sold 1,161 Idexx Laboratories shares in Q1 2026, an estimated $744K.
Idexx Laboratories made up 0.07% of Chevy Chase Trust's portfolio in Q1 2026, its #248 holding.
Chevy Chase Trust first reported a position in Idexx Laboratories in Q1 2017 and has held it in 37 quarters since.
Chevy Chase Trust's Idexx Laboratories position peaked at $34.4M in Q2 2021.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.